Intracerebroventricular administration of CYX-6, a potent μ-opioid receptor agonist, a δ- and κ-opioid receptor antagonist and a biased ligand at μ, δ & κ-opioid receptors, evokes antinociception with minimal constipation and respiratory depression in rats in contrast to morphine

2020 ◽  
Vol 871 ◽  
pp. 172918 ◽  
Author(s):  
Mohammad Zafar Imam ◽  
Andy Kuo ◽  
Sussan Ghassabian ◽  
Yunxin Cai ◽  
Yajuan Qin ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Respiratory Depression ◽  
Opioid Receptor ◽  
Opioid Receptors ◽  
Receptor Agonist ◽  
Intracerebroventricular Administration ◽  
Opioid Receptor Antagonist ◽  
Opioid Receptor Agonist ◽  
Μ Opioid Receptor

Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy µ opioid receptor agonist and a δ opioid receptor antagonist

2020 ◽  
Vol 237 (12) ◽  
pp. 3591-3602
Author(s):  
Sanjana Mada ◽  
Lisa R. Gerak ◽  
Amélie Soyer ◽  
David R. Maguire ◽  
Zehua Hu ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Opioid Receptor ◽  
Receptor Agonist ◽  
Behavioral Effects ◽  
Opioid Receptor Antagonist ◽  
Opioid Receptor Agonist ◽  
Δ Opioid Receptor

scholarly journals The μ-opioid receptor agonist morphine, but not agonists at δ- or κ-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors

2008 ◽  
Vol 154 (5) ◽  
pp. 1143-1149 ◽  
Author(s):  
D Da Fonseca Pacheco ◽  
A Klein ◽  
A De Castro Perez ◽  
C M Da Fonseca Pacheco ◽  
J N De Francischi ◽  
...  
Keyword(s):  
Opioid Receptor ◽  
Opioid Receptors ◽  
Receptor Agonist ◽  
Cannabinoid Receptors ◽  
Opioid Receptor Agonist ◽  
Μ Opioid Receptor
Sign in / Sign up

Export Citation Format

Share Document